欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号HU/H/0510/002
药品名称Paliperidon Krka 6 mg prolonged-release tablets
活性成分
    • paliperidone 6.0 mg
剂型Prolonged-release tablet
上市许可持有人KRKA, d.d., Novo mesto Šmarješka cesta 6 8501 Slovenia
参考成员国 - 产品名称Hungary (HU)
互认成员国 - 产品名称
    • Denmark (DK)
      Paliperidon TAD
    • Belgium (BE)
      Paliperidon Krka 6 mg tabletten met verlengde afgifte
    • Iceland (IS)
      Paliperidon Krka 6 mg forðatafla
    • Spain (ES)
    • Italy (IT)
    • Sweden (SE)
    • Cyprus (CY)
      Paliperidon TAD 6mg prolonged-release tablets
    • Ireland (IE)
许可日期2018/03/22
最近更新日期2022/04/28
药物ATC编码
    • N05AX13 paliperidone
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase